The effect of vitreomacular adhesion in exudative age-related macular degeneration on the results of ranibizumab intravitreal injection

QR Code

The effect of vitreomacular adhesion in exudative age-related macular degeneration on the results of ranibizumab intravitreal injection

Hiroyuki Suzuki,1 Seita Morishita,1 Ryohsuke Kohmoto,1 Masanori Fukumoto,1 Takaki Sato,1 Teruyo Kida,1 Mari Ueki,1 Hidehiro Oku,1 Kimitoshi Nakamura,2 Tsunehiko Ikeda1 1Department of Ophthalmology, Osaka Medical College, Takatsuki-City, Osaka, Japan; 2Nakamura Eye Clinic, Matsumoto-City, Nagano, Ja...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Suzuki H, Morishita S, Kohmoto R, Fukumoto M, Sato T, Kida T, Ueki M, Oku H, Nakamura K, Ikeda T
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2017
Sujets:	age-related macular degeneration vitreomacular adhesion anti-VEGF therapy ranibizumab optical coherence tomography Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/ec842e4caac94da99a3fd3f97431c6cb
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Visual outcome of intravitreal ranibizumab for exudative age-related macular degeneration: timing and prognosis
par: Canan H, et autres
Publié: (2014)

Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration
par: Dervenis N, et autres
Publié: (2016)

Vitreoretinal interface abnormalities in diabetic macular edema and effectiveness of anti-VEGF therapy: an optical coherence tomography study
par: Kulikov AN, et autres
Publié: (2017)

Retrospective Study of Ellipsoid Zone Integrity Following Treatment with Intravitreal Ocriplasmin (OZONE Study)
par: Drenser KA, et autres
Publié: (2021)

Clinical Features of Vitreomacular Traction Syndrome with Peripheral Vitreoretinal Adhesion
par: Fukumoto M, et autres
Publié: (2020)

Comment on: “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes”
par: Kaya A
Publié: (2016)

Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema
par: Fong AH, et autres
Publié: (2013)

Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes Group
par: Amoaku W, et autres
Publié: (2018)

Location of submacular hemorrhage as a predictor of visual outcome after intravitreal ranibizumab for age-related macular degeneration
par: Karagiannis D, et autres
Publié: (2017)

Real-World Visual And Clinical Outcomes For Patients With Neovascular Age-Related Macular Degeneration Treated With Intravitreal Ranibizumab: An 8-Year Observational Cohort (AMD8)
par: Horner F, et autres
Publié: (2019)

Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration
par: Koike N, et autres
Publié: (2019)

Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration
par: Michalska-Małecka K, et autres
Publié: (2016)

Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trial
par: Gallemore RP, et autres
Publié: (2017)

Visual acuity loss associated with excessive “dry macula” in exudative age-related macular degeneration
par: Takahashi H, et autres
Publié: (2018)

One-year outcome of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab: rapid morphologic recovery and subsequent visual improvement
par: Hirakata T, et autres
Publié: (2016)

Gene expression levels of the insulin-like growth factor family in patients with AMD before and after ranibizumab intravitreal injections
par: Strzalka-Mrozik B, et autres
Publié: (2017)

Prevalence of vitreomacular adhesion: an optical coherence tomography analysis in the retina clinic setting
par: Reichel E, et autres
Publié: (2016)

Age-dependent vitreous separation from the macula in a clinic population
par: Syed Z, et autres
Publié: (2016)

Long-Term Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Belgian Subanalysis from the Global Real-World LUMINOUSTM Study
par: Leys AM, et autres
Publié: (2020)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
par: Fouda SM, et autres
Publié: (2017)

Clinical characteristics and selection of treatment modality for patients with vitreomacular traction: real-world implementation of NICE guidance (TA297)
par: Pritchard EWJ, et autres
Publié: (2016)

Real-World Effectiveness, Treatment Pattern, and Safety of Ranibizumab in Korean Patients with Neovascular Age-Related Macular Degeneration: Subgroup Analyses from the LUMINOUS Study
par: Sagong M, et autres
Publié: (2021)

Effect of Funding Source on “Spin” in Studies of Ocriplasmin Therapy for Vitreomacular Traction and Macular Hole
par: Hubschman S, et autres
Publié: (2020)

Predictors of Early Diabetic Retinopathy Regression with Ranibizumab in the RIDE and RISE Clinical Trials
par: Singer M, et autres
Publié: (2020)

Are Dilated Fundus Examinations Needed for OCT-Guided Retreatment of Exudative Age-Related Macular Degeneration? A Prospective, Randomized, Pilot Study
par: Solomon SD, et autres
Publié: (2021)

Multifocal ERG and Microperimetry Changes in Response to Ranibizumab Treatment of Neovascular AMD: Randomized Phase 2 Open-Label Study
par: Asahi MG, et autres
Publié: (2020)

Evaluation of contrast sensitivity and other visual function outcomes in neovascular age-related macular degeneration patients after treatment switch to aflibercept from ranibizumab
par: Nixon DR, et autres
Publié: (2017)

Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN Study
par: Callizo J, et autres
Publié: (2019)

Cost-Effectiveness of Conbercept vs. Ranibizumab for Age-Related Macular Degeneration, Diabetic Macular Edema, and Pathological Myopia: Population-Based Cohort Study and Markov Model
par: Zhuang Cui, et autres
Publié: (2021)

Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration
par: Kabanarou SA, et autres
Publié: (2017)

Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab
par: Nudleman E, et autres
Publié: (2016)

Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
par: Thomas BJ, et autres
Publié: (2016)

Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better
par: Khanani AM, et autres
Publié: (2019)

Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study
par: Takahashi K, et autres
Publié: (2018)

Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
par: Pessoa B, et autres
Publié: (2021)

Two-year outcome of treat-and-extend aflibercept after ranibizumab in age-related macular degeneration and polypoidal choroidal vasculopathy patients
par: Azuma K, et autres
Publié: (2018)

Evaluation of contrast sensitivity and other visual function outcomes in diabetic macular edema patients following treatment switch to aflibercept from ranibizumab
par: Nixon DR, et autres
Publié: (2018)

Neovascular age-related macular degeneration: intraocular inflammatory cytokines in the poor responder to ranibizumab treatment
par: Pongsachareonnont P, et autres
Publié: (2018)

The Influence of Blue-Filtering Intraocular Lenses Implant on Exudative Age-Related Macular Degeneration: A Case–Control Study
par: Hamel T, et autres
Publié: (2021)

Ranibizumab in monotherapy and combined with photodynamic therapy for retinal angiomatous proliferation
par: Arias L, et autres
Publié: (2016)